The European Stroke Prevention Study (ESPS). Principal end-points. The ESPS Group.

North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. BMJ (1998) 2.15

Within-subject blood pressure level--not variability--predicts fatal and nonfatal outcomes in a general population. Hypertension (2012) 1.00

Stroke management. Ann Indian Acad Neurol (2011) 0.84

Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons. J Clin Neurol (2014) 0.81

Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag (2015) 0.79

Plasminogen activators and ischemic stroke: conditions for acute delivery. Semin Thromb Hemost (2013) 0.77

Antithrombotic Secondary Prevention After Stroke. Curr Treat Options Cardiovasc Med (2002) 0.77

Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease. Nat Rev Cardiol (2016) 0.75

Genetic dissection of platelet function in health and disease using systems biology. Hematol Oncol Clin North Am (2013) 0.75

Antithrombotics for secondary prevention of noncardioembolic ischaemic stroke. Nat Rev Neurol (2012) 0.75

Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clin Proc (2009) 0.75

Do we still need dipyridamole? Br J Clin Pharmacol (1998) 0.75

[Not Available]. Herzschrittmacherther Elektrophysiol (1998) 0.75

Antiplatelet therapy in the prevention of stroke. Drugs (1991) 0.75